Literature DB >> 16705178

A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions.

Yamei Niu1, François Roy, Frédéric Saltel, Charlotte Andrieu-Soler, Wen Dong, Anne-Lise Chantegrel, Rosita Accardi, Amélie Thépot, Nadège Foiselle, Massimo Tommasino, Pierre Jurdic, Bakary S Sylla.   

Abstract

Dok1 is believed to be a mainly cytoplasmic adaptor protein which down-regulates mitogen-activated protein kinase activation, inhibits cell proliferation and transformation, and promotes cell spreading and cell migration. Here we show that Dok1 shuttles between the nucleus and cytoplasm. Treatment of cells with leptomycin B (LMB), a specific inhibitor of the nuclear export signal (NES)-dependent receptor CRM1, causes nuclear accumulation of Dok1. We have identified a functional NES (348LLKAKLTDPKED359) that plays a major role in the cytoplasmic localization of Dok1. Src-induced tyrosine phosphorylation prevented the LMB-mediated nuclear accumulation of Dok1. Dok1 cytoplasmic localization is also dependent on IKKbeta. Serum starvation or maintaining cells in suspension favor Dok1 nuclear localization, while serum stimulation, exposure to growth factor, or cell adhesion to a substrate induce cytoplasmic localization. Functionally, nuclear NES-mutant Dok1 had impaired ability to inhibit cell proliferation and to promote cell spreading and cell motility. Taken together, our results provide the first evidence that Dok1 transits through the nucleus and is actively exported into the cytoplasm by the CRM1 nuclear export system. Nuclear export modulated by external stimuli and phosphorylation may be a mechanism by which Dok1 is maintained in the cytoplasm and membrane, thus regulating its signaling functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705178      PMCID: PMC1489083          DOI: 10.1128/MCB.01817-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  C-terminal sequences direct cyclin D1-CRM1 binding.

Authors:  Sharon Benzeno; J Alan Diehl
Journal:  J Biol Chem       Date:  2004-10-28       Impact factor: 5.157

2.  Presenilins mediate phosphatidylinositol 3-kinase/AKT and ERK activation via select signaling receptors. Selectivity of PS2 in platelet-derived growth factor signaling.

Authors:  David E Kang; Il Sang Yoon; Emanuela Repetto; Tracy Busse; Nader Yermian; Listya Ie; Edward H Koo
Journal:  J Biol Chem       Date:  2005-07-13       Impact factor: 5.157

3.  c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF.

Authors:  R Plattner; L Kadlec; K A DeMali; A Kazlauskas; A M Pendergast
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

4.  T cell regulation of p62(dok) (Dok1) association with Crk-L.

Authors:  M P Martelli; J Boomer; M Bu; B E Bierer
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

Review 5.  Focal adhesion kinase: in command and control of cell motility.

Authors:  Satyajit K Mitra; Daniel A Hanson; David D Schlaepfer
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

6.  IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation.

Authors:  Sanghoon Lee; Charlotte Andrieu; Frédéric Saltel; Olivier Destaing; Jessie Auclair; Véronique Pouchkine; Jocelyne Michelon; Bruno Salaun; Ryuji Kobayashi; Pierre Jurdic; Elliott D Kieff; Bakary S Sylla
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

7.  Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry.

Authors:  Incheol Shin; Jeremy Rotty; Frederick Y Wu; Carlos L Arteaga
Journal:  J Biol Chem       Date:  2004-12-03       Impact factor: 5.157

8.  Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1.

Authors:  N Kudo; B Wolff; T Sekimoto; E P Schreiner; Y Yoneda; M Yanagida; S Horinouchi; M Yoshida
Journal:  Exp Cell Res       Date:  1998-08-01       Impact factor: 3.905

9.  Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.

Authors:  Tomoharu Yasuda; Masaki Shirakata; Atsushi Iwama; Asuka Ishii; Yasuhiro Ebihara; Mitsujiro Osawa; Kazuho Honda; Hisaaki Shinohara; Katsuko Sudo; Kohichiro Tsuji; Hiromitsu Nakauchi; Yoichiro Iwakura; Hisamaru Hirai; Hideaki Oda; Tadashi Yamamoto; Yuji Yamanashi
Journal:  J Exp Med       Date:  2004-12-20       Impact factor: 14.307

10.  Role of Dok-1 and Dok-2 in leukemia suppression.

Authors:  Masaru Niki; Antonio Di Cristofano; Mingming Zhao; Hiroaki Honda; Hisamaru Hirai; Linda Van Aelst; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  J Exp Med       Date:  2004-12-20       Impact factor: 14.307

View more
  10 in total

1.  Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer.

Authors:  Tong Li; Beifang Li; Asgharpour Sara; Christine Ay; Wing Yan Leung; Yanquan Zhang; Yujuan Dong; Qiaoyi Liang; Xiang Zhang; Philip Weidner; Tobias Gutting; Hans-Michael Behrens; Christoph Röcken; Joseph Jy Sung; Matthias P Ebert; Jun Yu; Elke Burgermeister
Journal:  Oncoimmunology       Date:  2019-08-21       Impact factor: 8.110

2.  NF-kappaB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis.

Authors:  Ishraq Hussain; Ikbal Fathallah; Rosita Accardi; Jiping Yue; Djamel Saidj; Ruchi Shukla; Uzma Hasan; Tarik Gheit; Yamei Niu; Massimo Tommasino; Bakary S Sylla
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

3.  Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers.

Authors:  Amandine Saulnier; Thomas Vaissière; Jiping Yue; Maha Siouda; Marine Malfroy; Rosita Accardi; Marion Creveaux; Sinto Sebastian; Naveed Shahzad; Tarik Gheit; Ishraq Hussain; Mariela Torrente; Fausto Antonio Maffini; Luca Calabrese; Fausto Chiesa; Cyrille Cuenin; Ruchi Shukla; Ikbal Fathallah; Elena Matos; Alexander Daudt; Sergio Koifman; Victor Wünsch-Filho; Ana M B Menezes; Maria-Paula Curado; David Zaridze; Paolo Boffetta; Paul Brennan; Massimo Tommasino; Zdenko Herceg; Bakary S Sylla
Journal:  Int J Cancer       Date:  2011-09-22       Impact factor: 7.396

4.  Cutaneous human papillomavirus type 38 E7 regulates actin cytoskeleton structure for increasing cell proliferation through CK2 and the eukaryotic elongation factor 1A.

Authors:  Jiping Yue; Ruchi Shukla; Rosita Accardi; Isabelle Zanella-Cleon; Maha Siouda; Marie-Pierre Cros; Vladimir Krutovskikh; Ishraq Hussain; Yamei Niu; Shiqiong Hu; Michel Becchi; Pierre Jurdic; Massimo Tommasino; Bakary S Sylla
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

5.  The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor γ through spatial relocalization at helix 7 of its ligand-binding domain.

Authors:  Elke Burgermeister; Teresa Friedrich; Ivana Hitkova; Ivonne Regel; Henrik Einwächter; Wolfgang Zimmermann; Christoph Röcken; Aurel Perren; Matthew B Wright; Roland M Schmid; Rony Seger; Matthias P A Ebert
Journal:  Mol Cell Biol       Date:  2011-06-20       Impact factor: 4.272

6.  Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events.

Authors:  Debbie L Cunningham; Steve M M Sweet; Helen J Cooper; John K Heath
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

7.  mTOR-dependent phosphorylation controls TFEB nuclear export.

Authors:  Gennaro Napolitano; Alessandra Esposito; Heejun Choi; Maria Matarese; Valerio Benedetti; Chiara Di Malta; Jlenia Monfregola; Diego Luis Medina; Jennifer Lippincott-Schwartz; Andrea Ballabio
Journal:  Nat Commun       Date:  2018-08-17       Impact factor: 14.919

8.  P68 RNA helicase is a nucleocytoplasmic shuttling protein.

Authors:  Haizhen Wang; Xueliang Gao; Yun Huang; Jenny Yang; Zhi-Ren Liu
Journal:  Cell Res       Date:  2009-09-29       Impact factor: 25.617

9.  BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.

Authors:  Sayem Miah; Raghuveera Kumar Goel; Chenlu Dai; Natasha Kalra; Erika Beaton-Brown; Edward T Bagu; Keith Bonham; Kiven E Lukong
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

10.  Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer.

Authors:  Teresa Friedrich; Michaela Söhn; Tobias Gutting; Klaus-Peter Janssen; Hans-Michael Behrens; Christoph Röcken; Matthias P A Ebert; Elke Burgermeister
Journal:  EBioMedicine       Date:  2016-05-05       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.